Positions

Overview

  • During my career, I have dedicated a significant amount of time to both research and advocacy for the biomedical and biological scientific community. Currently, I am focused on science policy and biomedical education from the undergraduate to graduate level. I am committed to promote sound scientific policies, to support a diverse and inclusive scientific workforce, to support the training and professional development of the next generation of scientists, and to ensure that the scientific community makes a sincere effort to reach out to the non-scientific community to promote the good that science does for the well-being of all and to ensure that decision making is based on facts and the truth.

    I had the distinct honor of serving as President of the Federation of American Societies for Experimental Biology (FASEB, 2021-2022) and in this role, I had the pleasure of working with dedicated Federation staff and volunteers from 28 scientific societies, representing approximately 115,000 scientists. I also served as Vice President for Science Policy at FASEB (2018-2019), a position in which I oversaw the activities of the Science Policy Committee for the Federation. In these roles, I have had an opportunity to work with a wide range of scientific societies and to find common ground to advance sound science policies, to advocate for science and to ensure that we are making progress towards the reality of achieving a diverse and inclusive scientific workforce. I currently am President-Elect of the Society for Leukocyte Biology (SLB), and I look forward to serving SLB, which is a society that I have belonged to since I was a graduate student. I am a member of the Society for Experimental Biology and Medicine and serve on the Council for SEBM. Finally, I am a long-standing member of the American Association of Immunologists and have served on numerous committees for that organization. These experiences have afforded me the opportunity to gain significant knowledge and experience pertaining to critical issues impacting science and scientific societies that I feel I can use to benefit IUIS and its mission to strengthen the global community of immunologists.

    Throughout my career, I have focused on training the next generation and ensuring that trainees and early career scientists have the career and professional development opportunities that will enable them to succeed in a wide range of research-intensive and science-related careers. To that end, I served as the Chair of the Training and Career Opportunities Subcommittee at FASEB for 10 years. I also served as a founding Steering Committee member for the Professional Development Hub (pd/hub) and continue to work with this organization, which is dedicated to promoting career and professional development for trainees in the biomedical sciences. Most recently, I was elected to the Steering Committee for the Group on Research, Education and Training (GREAT Group), which is part of the American Association of Medical Colleges. The GREAT Group is dedicated to fostering the success of graduate students and postdoctoral fellows in achieving their career goals. Finally, I have been a strong proponent of broadening the reach of education in immunology and started one of the first dedicated undergraduate immunology programs in the US. I am a founding member of ImmunoReach, which is a dedicated group of immunology educators across the US and from other countries. ImmunoReach is focused on broadening interdisciplinary STEM education with a focus on immunology.

    Currently, I serve as the Director of the Immunology Theme in the Graduate Biomedical Sciences Program at UAB and I also serve as a Co-Director for the Undergraduate Immunology Program, which I founded in 2016. The UIP is the only dedicated undergraduate major in the United States that focuses on teaching the next generation about the immune system and its role in health and disease.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2022 Antigen and Immunogen: An Investigation into the Heterogeneity of Immunology Terminology in Learning ResourcesImmunoHorizons.  6:312-323. 2022
    2022 Kindlin-3 puts the brakes on B cell activation and differentiationJournal of Leukocyte Biology.  111:741-743. 2022
    2021 An Analysis of Factors That Influence Students to Pursue ImmunologyImmunoHorizons.  5:1021-1029. 2021
    2021 Inside the undergraduate immunology classroom: Current practices that provide a framework for curriculum consensus 2021
    2020 The Future of Undergraduate Immunology Education: Can a Comprehensive Four-Year Immunology Curriculum Answer Calls for Reform in Undergraduate Biology Education?ImmunoHorizons.  4:745-753. 2020
    2020 Using real-world examples of the COVID-19 pandemic to increase student confidence in their scientific literacy skillsBiochemistry and Molecular Biology Education.  48:678-684. 2020
    2019 Out of the Curricular Shadows: Revolutionizing Undergraduate Immunology EducationFrontiers in Immunology.  10. 2019
    2016 TREM-like transcript 2 is stored in human neutrophil primary granules and is up-regulated in response to inflammatory mediatorsJournal of Leukocyte Biology.  100:177-184. 2016
    2016 Biomedical science postdocs: An end to the era of expansion 2016
    2016 Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical featuresCancer Causes and Control.  27:81-91. 2016
    2014 Putting PhDs to work: Career planning for today's scientist 2014
    2014 Murine marginal zone B cells play a role in Vibrio cholerae LPS antibody responsesFEMS Immunology and Medical Microbiology.  70:153-157. 2014
    2013 The Actin and Tetraspanin Networks Organize Receptor Nanoclusters to Regulate B Cell Receptor-Mediated SignalingImmunity.  38:461-474. 2013
    2013 Lymphotoxin α1β2 expression on B cells is required for follicular dendritic cell activation during the germinal center responseEuropean Journal of Immunology.  43:348-359. 2013
    2012 Erratum: Writing a first grant proposal (Nature Immunology (2011) 13 (105-108))Nature Immunology.  13:621. 2012
    2012 Writing a first grant proposalNature Immunology.  13:106-108. 2012
    2011 Differential expression of the adaptor protein HSH2 controls the quantitative and qualitative nature of the humoral responseJournal of Immunology.  187:3565-3577. 2011
    2011 TLT2 potentiates neutrophil antibacterial activity and chemotaxis in response to G protein-coupled receptor-mediated signalingJournal of Immunology.  187:2346-2355. 2011
    2011 Marginal zone B cells regulate antigen capture by marginal zone macrophagesJournal of Immunology.  186:2172-2181. 2011
    2006 Trem-like transcript 2 is expressed on cells of the myeloid/granuloid and B lymphoid lineage and is up-regulated in response to inflammationJournal of Immunology.  176:6012-6021. 2006
    2006 Expression of the adaptor protein hematopoietic Src homology 2 is up-regulated in response to stimuli that promote survival and differentiation of B cellsJournal of Immunology.  176:4163-4172. 2006
    2005 The adaptor protein HSH2 attenuates apoptosis in response to ligation of the B cell antigen receptor complex on the B lymphoma cell line, WEHI-231Journal of Biological Chemistry.  280:3507-3515. 2005
    2003 The B cell coreceptor CD22 associates with AP50, a clathrin-coated pit adapter protein, via tyrosine-dependent interactionJournal of Immunology.  170:3534-3543. 2003
    2002 Evaluating function of transmembrane protein tyrosine phosphatase CD148 in lymphocyte biologyImmunologic Research.  26:153-166. 2002
    2002 AP2 adaptor complex-dependent internalization of CD5: Differential regulation in T and B cellsJournal of Immunology.  168:5612-5620. 2002
    2001 CD45 function is regulated by an acidic 19-amino acid insert in domain II that serves as a binding and phosphoacceptor site for casein kinase 2Journal of Immunology.  166:7208-7218. 2001
    2001 The role of the protein tyrosine phosphatase CD45 in regulation of B lymphocyte activationInternational Reviews of Immunology.  20:713-738. 2001
    2000 Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22Journal of Immunology.  165:5588-5596. 2000
    2000 Signal transduction and the coordination of B lymphocyte development and function I. Transduction of BCR signals from the cell membrane to the nucleus. Introduction.Current Topics in Microbiology and Immunology.  245:V-X. 2000
    1999 Signal transduction via the B-cell antigen receptor: The role of protein tyrosine kinases and protein tyrosine phosphatasesCurrent Topics in Microbiology and Immunology.  245 I:1-51. 1999
    1999 Analysis of tyro sine phosphorylation-dependent interactions between stimulatory effector proteins and the B cell co-receptor CD22Journal of Biological Chemistry.  274:18769-18776. 1999
    1999 CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1Journal of Immunology.  162:5278-5286. 1999
    1998 Major histocompatibility class II-mediated signal transduction is regulated by the protein-tyrosine phosphatase CD45Journal of Biological Chemistry.  273:11970-11979. 1998
    1998 Association of MHC class II molecules with transmembrane protein(s) is required for the formation of a competent signaling complex in B cells 1998
    1998 CD45 regulates the interaction between CD22 and SHP-1 in B cells 1998
    1998 Interaction of AP50 with the cytoplasmic domain of murine CD22.2 1998
    1997 Kinase-Independent Potentiation of B Cell Antigen Receptor-Mediated Signal Transduction by the Protein Tyrosine Kinase SrcJournal of Immunology.  159:4823-4833. 1997
    1997 Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fcγ immunoreceptor tyrosine-based inhibition motif peptide motifMolecular and Cellular Biology.  17:4305-4311. 1997
    1997 The role of CD45 in signal transductionAdvances in Immunology.  66:1-65. 1997
    1996 Yersinia enterocolitica envelope proteins that are crossreactive with the thyrotropin receptor (TSHR) also have B-cell mitogenic activityJournal of Autoimmunity.  9:509-516. 1996
    1995 The intracellular signal transduction mechanism of interleukin 5 in eosinophils: The involvement of lyn tyrosine kinase and the ras-raf-1-MEK-microtubule-associated protein kinase pathwayJournal of Experimental Medicine.  181:1827-1834. 1995
    1995 A role in B cell activation for CD22 and the protein tyrosine phosphatase SHPScience.  269:242-244. 1995
    1995 Mechanism of inhibition of eosinophil activation by transforming growth factor-β: Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factorJournal of Immunology.  155:4454-4458. 1995
    1995 Potentiation of B‐Cell Antigen Receptor‐mediated Signal Transduction by the Heterologous src Family Protein Tyrosine Kinase, srcAnnals of the New York Academy of Sciences.  766:214-215. 1995
    1994 Multiple components of the B cell antigen receptor complex associate with the protein tyrosine phosphatase, CD45Journal of Biological Chemistry.  269:17238-17244. 1994
    1994 Regulation of B-cell activation by CD45: a question of mechanismTrends in Immunology.  15:399-406. 1994
    1993 Administration of anti-CD45 mAb specific for a B cell-restricted epitope abrogates the B cell response to a T-dependent antigen in vivoJournal of Immunology.  151:5936-5947. 1993
    1992 Regulation of basal tyrosine phosphorylation of the B cell antigen receptor complex by the protein tyrosine phosphatase, CD45Journal of Immunology.  149:3182-3190. 1992
    1992 The MB-1/B29 heterodimer couples the B cell antigen receptor to multiple src family protein tyrosine kinasesJournal of Immunology.  149:1548-1555. 1992
    1991 Regulation of B cell antigen receptor signal transduction and phosphorylation by CD45Science.  252:1839-1842. 1991
    1991 Regulation of B cell antigen receptor signal transduction and phosphorylation by CD45.Science.  252. 1991
    1991 The B-cell antigen receptor complexTrends in Immunology.  12:196-201. 1991
    1990 Endogenously secreted IL-4 is required for mouse thymocytes to become cytotoxic. Human, but not mouse, IL-2 induces a functionally immature thymic subset to secrete IL-4 and become CTLImmunology.  70:478-484. 1990
    1990 Improved method for measuring intracellular Ca++ with fluo‐3Bioimaging.  11:923-927. 1990
    1990 Membrane IgM and IgD molecules fail to transduce Ca2+ mobilizing signals when expressed on differentiated B lineage cellsJournal of Immunology.  144:3272-3280. 1990
    1989 Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligandsJournal of Immunology.  143:1032-1039. 1989
    1989 Production of multiple lymphokines by the A20.1 B cell lymphoma after cross-linking of membrane Ig by immobilized anti-IgJournal of Immunology.  143:881-889. 1989
    1988 B cell stimulatory factor 1 induces lobster agglutinin 1-separated mouse thymocytes to express cytotoxic T lymphocyte activityJournal of Immunology.  141:145-150. 1988
    1988 Biochemical characterization of proteins that co-purify with class II antigens of the murine MHCJournal of Immunology.  140:1930-1938. 1988
    1987 Coupling of B cell surface Ig, Ia and BSF1 receptors to intracellular "second messengers".Advances in Experimental Medicine and Biology.  213:195-205. 1987
    1987 Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytesNature.  327:629-632. 1987
    1987 Transmembrane Signals and Intracellular “Second Messengers” in the Regulation of Quiescent B‐Lymphocyte ActivationImmunological Reviews.  95:37-57. 1987
    1986 BSF1 induces membrane protein phosphorylation but not phosphoinositide metabolism, Ca2+ mobilization, protein kinase C translocation, or membrane depolarization in resting murine B lymphocytesJournal of Immunology.  137:3664-3670. 1986
    1986 Modulation of cyclic AMP-dependent protein kinase isozyme expression associated with activation of a macrophage cell lineJournal of Immunology.  136:270-277. 1986
    1984 Differential expression of cAMP dependent protein kinases in operationally defined populations of macrophages 1984
    1984 Inhibition of macrophage-mediated tumor cell destruction by oxidized lipoproteins 1984

    Book

    Year Title Altmetric
    1999 Signal transduction and the coordination of B lymphocyte development and function II. Translation of BCR signals to specific physiologic outcomes: Preface.  Ed. 245 II.  1999
    1999 Signal transduction and the coordination of B lymphocyte development and function I: Preface.  Ed. 245 I.  1999

    Chapter

    Year Title Altmetric
    2009 Signal Transduction via the B Cell Antigen Receptor: A Crucial Regulator of B Cell Biology.  2689-2698. 2009
    2003 Signal Transduction via the B-Cell Antigen Receptor: A Crucial Regulator of B-Cell Biology.  555-564. 2003

    Research Overview

  • Analysis of the Molecular and Functional Role of the Adaptor Protein HSH2. Studies are ongoing to elucidate the functional role that the adaptor protein HSH2 plays in regulating B cell biology. HSH2 is selectively expressed in cells of the B lineage and its expression is up-regulated in vitro in response to agonists that promote B cell survival and differentiation, including CD40L, BLyS, LPS and CpG DNA. Recent studies using transgenic mice have revealed that HSH2 plays a critical role in regulating terminal differentiation of B cells into antibody secreting plasma cells. Constitutive expression of HSH2 in the B lineage results in a significant decrease in serum immunoglobulin (Ig) titers. Moreover, immunization of HSH2 Tg mice with either T-dependent or T-independent antigens induces only a modest antigen-specific IgM response and very little class-switched Ig production. Conversely immunization of mice in which HSH2 is expressed at only one fifth the normal amount in B cells (HSH2 hypomorph mice), leads to enhanced production of antigen-specific class switched Ig both in terms of the kinetics and magnitude of the response when compared to wild type mice. Based on these observations, it is likely that HSH2 plays a critical role in regulating Ig class switching and terminal differentiation of B cells. Future studies will be conducted to:

    Identify important regions/motifs of HSH2 that are involved in its function
    Identify the proteins that interact with HSH2 in B lymphocytes and assess their functional importance
    Characterize the molecular mechanisms that control HSH2 expression in B cells
    Generate conditional knockout mice to examine the importance of HSH2 in regulation of B cell development, activation and differentiation
    Analysis of the Molecular and Functional Role of the Transmembrane Receptor Trem-Like Transcript 2 (TLT2). The genes encoding mouse and human TLT2 were cloned in our laboratory. Subsequent experiments in mice demonstrated that TLT2 is expressed on B cells, neutrophils and macrophages. With respect to the B lineage, TLT2 is expressed early during development, prior to the BCR and can be detected on both fetal liver- and bone marrow-derived B cell progenitors. Although TLT2 is expressed on all B cells in the periphery, its level is higher on transitional, marginal zone and B-1 B cells when compared to follicular B cells. Expression of TLT2 can be detected on peritoneal and alveolar macrophages but not on monocytes in the blood. Finally, TLT2 is expressed on neutrophils and neutrophil progenitors. Importantly, TLT2 is significantly up-regulated on macrophages and neutrophils in response to inflammatory stimuli such as LPS or Staphylococcal superantigens. Neutrophils also contain large pools or preformed TLT2 in their granules that are rapidly released in response to activating stimuli such as FMLP or PMA. Recent studies have shown that TLT2 plays an important role as a potentiating receptor that enhances the neutrophil response to agonists that bind to and signal through 7-transmembrane, G protein-coupled receptors. Specifically, TLT2 cross-linking enhances ROS production, degranulation and migration of neutrophils stimulated with several agonists, including fMLP, and various chemokines. Thus, TLT2 is likely to play an important role in the innate immune response and is likely to functionally bridge components of the innate response with the adaptive response. Future studies will be conducted to:

    Characterize TLT2 expression and function in human immune cells
    Assess the functional role played by TLT2 in immune responses to infectious organisms and during the inflammatory response; conditional knockout mice will be generated for these studies, as well as Tg mice that conditionally express a soluble form of TLT2.
    Identify the ligand(s) for TLT2 using several molecular and biochemical approaches
    Identify interacting signal transduction proteins and their associated pathways that mediate the functional effects of TLT2 on immune cells
    Characterization of Molecular Mechanisms that Regulate 1) Marginal Zone Development and Homeostasis and 2) Initiation and Maintenance of the Germinal Center Reaction. CD19 is a B cell transmembrane protein that is required for both the marginal zone (MZ) and germinal center (GC) B cell responses. The MZ provides a rapid response against pathogens that have entered the circulation, which otherwise can be deadly in hours. We have found that MZ macrophages are absent and dendritic cells were abnormally distributed in mice that lack CD19. Despite these structural defects, adoptive transfer studies demonstrate that failure of CD19-/- B cells to enter the MZ is B cell-intrinsic. Reconstitution of MZ B cells was followed by recovery of MZ macrophages and dendritic cells, suggesting that MZ B cells control the organization of other cells in the MZ. Studies will be conducted to:

    Determine the mechanisms by which CD19 controls differentiation and localization of MZ B cells
    Determine the mechanisms by which MZ B cells regulate other MZ cells
    The GC is the site of affinity maturation and the generation of B cell memory, which are essential for inducing long-lasting immunity with vaccines. Preliminary data indicate that Follicular Dendritic Cell (FDC) activation fails in mice that lack CD19. The lack of FDC activation is likely critical to the failure of the GC pathway, and hence T-dependent antibody responses. CD19 could contribute to FDC activation through effects on activation of follicular B cells, on formation of immune complexes through effects on IgM, and on MZ-dependent trafficking of antigen into the follicle. Studies will be performed to:

    Determine the role of CD19 in promoting LTb expression of GC B cells and the role of LTb in activation of FDC
    Determine the role of immune complex formation in the initiation of the GC response
    Examine the role of the VLA-4:VCAM-1 interaction between B cells and FDCs, respectively for maintenance of the GC response

    Personal Interests
    When not working he enjoys cooking and gardening, as well as fishing or hiking.
  • Teaching Overview

  • I have focused a significant portion of my career on education at multiple levels, including undergraduate, graduate and professional education. In all three areas I have extensive experience teaching, directing courses and serving in an administrative role. In the medical education space, I was the Course Director for Medical Microbiology for several years and held leadership positions in medical education at UAB, including serving as Vice-Chair and Chair of the Integrated Medical Sciences Committee (2003-2006) and serving on the Medical Education Committee (MEC) Executive Committee (2003-2006). I also served as the Assistant and then Associate Director for the Medical Scientist Training Program at UAB (2005-2018). As a result, I have extensive experience in the combined MD/PhD training sphere. With respect to graduate education, once again I have extensive experience teaching, serving as a course director for multiple courses and more recently serving as the Graduate Biomedical Sciences Immunology Theme Director. Finally, my dedication to these efforts has consistently been recognized; I have received 9 awards for education over the years, including the UAB President’s Award for Excellence in Teaching and the Dean’s Excellence in Teaching award, and I have been nominated for or awarded the Argus Award for teaching in the School of Medicine 15 times. My involvement in medical and graduate education has also included activities at the national level. In medical education, I have served on various committees at the National Board of Medical Examiners for the past 10 years, I served on the Program Committee for the Association of Medical School Microbiology and Immunology Chairs for 6 years; a group that focuses on medical education in Microbiology and Immunology. I am also actively involved with the International Association of Medical Science Educators and served on the Publication Committee for 13 years.

    In addition to mentoring 24 graduate students and postdoctoral fellows in my own laboratory and serving as the Director for the GBS Immunology Theme at UAB since 2015, I have been active at the national level in promoting numerous initiatives pertaining to graduate and postdoctoral education. I served as the Chair of the Training and Career Opportunities (TCO) Subcommittee at the Federation of American Societies for Experimental Biology (FASEB) for 10 years and was one of the early proponents for the adoption of Individual Development Plans (IDPs). Indeed, we conducted and published one of the earliest surveys regarding the use of IDPs in the biomedical sciences. During my time as Chair of the TCO, the subcommittee developed a web-based resource that highlighted all the career and professional development (CPD) activities offered by the member societies of FASEB. This resource was designed to foster awareness of and participation by graduate and postdoctoral trainees in these opportunities. In 2018 I, along with others from FASEB, organized a stakeholder workshop in partnership with the AAMC, HHMI, CGS and NIGMS to discuss the new NIGMS FOA for institutional training grants. This workshop focused on competency-based training and the use of logic models to develop evidence-based approaches to foster the objectives of the new T32 guidelines. I am a strong proponent of ongoing efforts to develop approaches to assess the acquisition of transferrable competencies by trainees because these competencies are essential to future career success whether that be in a research-intensive position or in a science-related career. Finally, as Chair of the TCO Subcommittee, I was actively engaged in studies to track trends in the number of postdoctoral fellows in the biomedical sciences and co-authored a paper that gained wide-spread national attention demonstrating the first consistent decline in postdoctoral fellows in the US. Outcomes for individuals who pursue postdoctoral training are currently a critical issue as there are trends showing that increasing numbers of postdoctoral trainees are choosing to pursue careers in industry and in science-related careers, with a concurrent decrease in the number of individuals who are choosing to remain in academia.

    I was one of the founding Steering Committee members of a new effort to create a national center for the dissemination of evidence-based training and resources to promote career and professional development for trainees called Professional Development Hub (pd/hub) and I still serve on workgroups for this organization. As a Steering Committee member, I was part of a team that hosted a stakeholder meeting involving individuals from 9 stakeholder groups in collaboration with the NSF, Burroughs Wellcome Fund, ASBMB and HHMI. This meeting, which was held in the summer of 2019 at the HHMI Janelia Research Center, focused on identifying challenges, as well as actions to foster enhanced dissemination of resources and support for career and professional development for trainees. Most recently, I was elected to the Graduate Steering Committee of the GREAT Group at the AAMC, which focuses on PhD, postdoctoral and MD/PhD training issues.

    At the international level, I have been involved with the Organization for PhD Education in Biomedicine and Health Sciences in the European System (ORPHEUS) through my former role as President of FASEB. ORPHEUS is an association of European biomedical and health science faculties and institutions that is committed to safeguarding the reputation of the PhD as a research degree and strengthening career opportunities for PhD graduates across Europe. I have attended their meetings and have been an invited speaker. Through these activities, I have had the opportunity to meet educational leaders from across Europe and I have had the opportunity to learn about the various challenges and opportunities that different countries experience. It is my goal to continue my relationship with ORPHEUS going forward and it would be my hope that my ongoing relationship with ORPHEUS will foster my ability to build and sustain partnerships with institutions across Europe.

    At the undergraduate level, I created the Undergraduate Immunology Program (UIP) at UAB, which is unique in the United States based on its focus on educating students about the Immune system and its role in health and disease. The program was officially approved for the fall of 2016, and we welcomed our first class in the fall of 2017. The program grew to over 100 majors in 4 years and our fourth class will graduate this spring. This program has gained a significant amount of attention both locally and nationally. An important outcome associated with the creation of the UIP at UAB is the fact that graduates from this program are now applying to professional school and graduate school at UAB and elsewhere. For our most recent round of applications to the GBS Immunology Theme at UAB, 25% of the applicants we interviewed were graduates from the UIP. This is a clear demonstration of the fact that one of the benefits of creating such a program is that we have effectively developed a pipeline that will provide our graduate program with outstanding applicants who have a strong background in immunology and who have performed extensive undergraduate research, which is a requirement of the UIP.

    In addition, my colleagues and I have published several papers highlighting the important role that immunology can play in meeting the calls for reforms in STEM education that are focused on promoting interdisciplinary learning. I am also one of the founding members of the national network called ImmunoReach. The mission of ImmunoReach is to promote immunology education at the undergraduate level across the United States. ImmunoReach recently received funding from the National Science Foundation, and we are currently in the process of expanding the network to foster the development of resources for education in immunology. As part of that effort, we are partnering with Cell Collective to develop computer modelling simulations to teach immunology to promote education in immunology using systems-based approaches.
  • Teaching Activities

  • 01-530 - MICROBIOLOGY/IMMUNOLOGY (Fall Term 2007)
  • 01-530 - MICROBIOLOGY/IMMUNOLOGY (Fall Term 2007)
  • 01-530R - MICROBIOLOGY REMEDIATION (Fall Term 2008)
  • 32-241 - MICROBIOLOGY RESEARCH (Fall Term 2015)
  • 32-241 - MICROBIOLOGY RESEARCH (Spring Term 2013)
  • GBS740A - INTRODUCTION TO IMMUNOLOGY A (Spring Term 2017)
  • GBS740A - INTRODUCTION TO IMMUNOLOGY A (Spring Term 2018)
  • GBS740A - Intro to Immunology Part 1 (Spring Term 2016)
  • GBS740A - Intro to Immunology Part 1 (Spring Term 2017)
  • GBS740A - Intro to Immunology Part 1 (Spring Term 2018)
  • GBS740A - Intro to Immunology Part 1 (Spring Term 2019)
  • GBS740A - Intro to Immunology Part 1 (Spring Term 2020)
  • GBS740A - Intro to Immunology Part 1 (Spring Term 2021)
  • GBS740A - Intro to Immunology Part 1 (Spring Term 2022)
  • GBS740A - Intro to Immunology Part 1 (Spring Term 2023)
  • GBS740B - INTRODUCTION TO IMMUNOLOGY B (Spring Term 2017)
  • GBS740B - Intro to Immunology Part 2 (Spring Term 2016)
  • GBS740B - Intro to Immunology Part 2 (Spring Term 2017)
  • GBS740B - Intro to Immunology Part 2 (Spring Term 2018)
  • GBS740B - Intro to Immunology Part 2 (Spring Term 2019)
  • GBS740B - Intro to Immunology Part 2 (Spring Term 2020)
  • GBS740B - Intro to Immunology Part 2 (Spring Term 2021)
  • GBS740B - Intro to Immunology Part 2 (Spring Term 2022)
  • GBS740B - Intro to Immunology Part 2 (Spring Term 2023)
  • GBSC701 - Seminars (Spring Term 2017)
  • GBSC722 - Special Topics (Fall Term 2017)
  • GBSC722 - Special Topics (Spring Term 2018)
  • GBSC742 - Student Theme Meeting Course (Fall Term 2018)
  • GBSC742 - Student Theme Meeting Course (Fall Term 2019)
  • GBSC742 - Student Theme Meeting Course (Fall Term 2020)
  • GBSC742 - Student Theme Meeting Course (Fall Term 2021)
  • GBSC742 - Student Theme Meeting Course (Fall Term 2022)
  • GBSC742 - Student Theme Meeting Course (Spring Term 2019)
  • GBSC742 - Student Theme Meeting Course (Spring Term 2020)
  • GBSC742 - Student Theme Meeting Course (Spring Term 2021)
  • GBSC742 - Student Theme Meeting Course (Spring Term 2022)
  • GBSC742 - Student Theme Meeting Course (Spring Term 2023)
  • HC117 - Honors Seminar: Science/Math (Fall Term 2019)
  • HC117 - Honors Seminar: Science/Math (Fall Term 2020)
  • HC117 - Honors Seminar: Science/Math (Fall Term 2021)
  • HC117 - Honors Seminar: Science/Math (Fall Term 2022)
  • MIC150 - Current Topics In Immunology (Spring Term 2019)
  • MIC150 - Current Topics In Immunology (Spring Term 2020)
  • MIC150 - Current Topics In Immunology (Spring Term 2021)
  • MIC150 - Current Topics In Immunology (Spring Term 2022)
  • MIC150 - Current Topics In Immunology (Spring Term 2023)
  • MIC250 - Seminars in Immunology (Fall Term 2018)
  • MIC250 - Seminars in Immunology (Fall Term 2019)
  • MIC250 - Seminars in Immunology (Fall Term 2020)
  • MIC250 - Seminars in Immunology (Fall Term 2021)
  • MIC250 - Seminars in Immunology (Fall Term 2022)
  • MIC275 - Introductory Immunology (Fall Term 2021)
  • MIC275 - Introductory Immunology (Spring Term 2019)
  • MIC275 - Introductory Immunology (Spring Term 2020)
  • MIC275 - Introductory Immunology (Spring Term 2021)
  • MIC275 - Introductory Immunology (Spring Term 2022)
  • MIC275 - Introductory Immunology (Spring Term 2023)
  • MIC275 - Introductory Immunology (Summer Term 2022)
  • MIC398 - Undergraduate Research Immu (Fall Term 2020)
  • MIC398 - Undergraduate Research Immu (Fall Term 2021)
  • MIC398 - Undergraduate Research Immu (Fall Term 2022)
  • MIC398 - Undergraduate Research Immu (Spring Term 2020)
  • MIC398 - Undergraduate Research Immu (Spring Term 2021)
  • MIC398 - Undergraduate Research Immu (Spring Term 2022)
  • MIC398 - Undergraduate Research Immu (Spring Term 2023)
  • MIC398 - Undergraduate Research Immu (Summer Term 2022)
  • MIC400 - Microbiome in Health/Immunity (Spring Term 2021)
  • MIC400 - Microbiome in Health/Immunity (Spring Term 2022)
  • MIC401 - Innate Immunity (Fall Term 2021)
  • MIC401 - Innate Immunity (Fall Term 2022)
  • MIC402 - Adaptive Immunity (Spring Term 2020)
  • MIC402 - Adaptive Immunity (Spring Term 2021)
  • MIC402 - Adaptive Immunity (Spring Term 2022)
  • MIC402 - Adaptive Immunity (Spring Term 2023)
  • MIC403 - Immunity Against Pathogens (Fall Term 2020)
  • MIC403 - Immunity Against Pathogens (Fall Term 2021)
  • MIC404 - Immune-Mediated Dieseases (Spring Term 2021)
  • MIC404 - Immune-Mediated Dieseases (Spring Term 2022)
  • MIC404 - Immune-Mediated Dieseases (Spring Term 2023)
  • MIC410 - Special Topics in Immunology (Fall Term 2019)
  • MIC410 - Special Topics in Immunology (Summer Term 2019)
  • MIC450 - Current Topics in Immunology (Spring Term 2018)
  • MIC490 - Immunology Thesis (Fall Term 2022)
  • MIC490 - Immunology Thesis (Spring Term 2022)
  • MIC490 - Immunology Thesis (Spring Term 2023)
  • MIC492 - Research Seminar in Immunology (Fall Term 2020)
  • MIC492 - Research Seminar in Immunology (Fall Term 2021)
  • MIC492 - Research Seminar in Immunology (Fall Term 2022)
  • MIC492 - Research Seminar in Immunology (Spring Term 2021)
  • MIC492 - Research Seminar in Immunology (Spring Term 2022)
  • MIC492 - Research Seminar in Immunology (Spring Term 2023)
  • MIC498 - Honors Research in Immunology (Fall Term 2019)
  • MIC498 - Honors Research in Immunology (Fall Term 2021)
  • MIC498 - Honors Research in Immunology (Fall Term 2022)
  • MIC498 - Honors Research in Immunology (Spring Term 2019)
  • MIC498 - Honors Research in Immunology (Spring Term 2020)
  • MIC498 - Honors Research in Immunology (Spring Term 2021)
  • MIC498 - Honors Research in Immunology (Spring Term 2022)
  • MIC498 - Honors Research in Immunology (Spring Term 2023)
  • MIC498 - Honors Research in Immunology (Summer Term 2019)
  • MIC498 - Honors Research in Immunology (Summer Term 2022)
  • MIC499 - Honors Seminar in Immunology (Fall Term 2022)
  • MIC499 - Honors Seminar in Immunology (Spring Term 2020)
  • MIC499 - Honors Seminar in Immunology (Spring Term 2021)
  • MIC499 - Honors Seminar in Immunology (Spring Term 2022)
  • MIC499 - Honors Seminar in Immunology (Spring Term 2023)
  • MIC600 - Microbiome in Health/Immunity (Spring Term 2021)
  • MIC600 - Microbiome in Health/Immunity (Spring Term 2022)
  • MIC601 - Innate Immune System (Fall Term 2021)
  • MIC601 - Innate Immune System (Fall Term 2022)
  • MIC602 - Adaptive Immune System (Spring Term 2020)
  • MIC602 - Adaptive Immune System (Spring Term 2021)
  • MIC602 - Adaptive Immune System (Spring Term 2022)
  • MIC602 - Adaptive Immune System (Spring Term 2023)
  • MIC603 - Host-Pathogen Interactions (Fall Term 2020)
  • MIC603 - Host-Pathogen Interactions (Fall Term 2021)
  • MIC604 - Immune-Mediated Diseases (Spring Term 2021)
  • MIC604 - Immune-Mediated Diseases (Spring Term 2022)
  • MIC604 - Immune-Mediated Diseases (Spring Term 2023)
  • MIC660 - Intro Immune System (Fall Term 2022)
  • MIC660 - Intro Immune System (Spring Term 2023)
  • MIC661 - Immune-mediated Diseases (Spring Term 2023)
  • MIC700 - Adv Course in Autoimmunity (Spring Term 2010)
  • MIC710 - Dev Comm Skills for Bio (Fall Term 2016)
  • MIC710 - Dev Comm Skills for Bio (Spring Term 2016)
  • MIC799 - Dissert Res Molecular Cell Bio (Fall Term 2016)
  • MSTP794 - Translational Research Seminar (Fall Term 2016)
  • MSTP794 - Translational Research Seminar (Fall Term 2017)
  • MSTP794 - Translational Research Seminar (Spring Term 2015)
  • MSTP794 - Translational Research Seminar (Spring Term 2016)
  • MSTP794 - Translational Research Seminar (Spring Term 2017)
  • MSTP794 - Translational Research Seminar (Spring Term 2018)
  • MSTP794 - Translational Research Seminar (Summer Term 2015)
  • MSTP794 - Translational Research Seminar (Summer Term 2016)
  • MSTP794 - Translational Research Seminar (Summer Term 2017)
  • MSTP794 - Translational Research Seminar (Summer Term 2018)
  • OBHS111 - Fundamentals of Dent and Opt I (Fall Term 2009)
  • OBHS111 - Fundamentals of Dent and Opt I (Fall Term 2010)
  • OBHS111 - Fundamentals of Dent and Opt I (Fall Term 2011)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTIST (Fall Term 2008)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTIST (Fall Term 2009)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2010)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2011)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2012)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2013)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2014)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2015)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2015)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2016)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2016)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2017)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2017)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2017)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2018)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2019)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2019)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2020)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2021)
  • STP2043 - SURVIVAL SKILLS FOR PHYSICIAN SCIENTISTS (Fall Term 2022)
  • Education And Training

  • Doctor of Philosophy in Microbiology, Ohio State University System : Columbus 1985
  • Full Name

  • Louis Justement
  • Fax

  • 205-996-6749